Hamilton Beach Brands (HBB): Customer Relationships, Concentration and Contracting Posture
Hamilton Beach Brands designs, markets and distributes small electrical and specialty appliances and monetizes through product sales, brand licensing and a growing Health segment that leases connected devices and sells software/licenses to pharmaceutical and specialty pharmacy customers. Revenue is heavily retail-driven and concentrated: large-box and ecommerce retailers supply the bulk of product sales, while selective multiyear brand agreements and month-to-month device leases provide recurring and licensing income. For a full view of HBB’s customer footprint, see https://nullexposure.com/.
Quick take: what matters to investors
Hamilton Beach’s topline is a mix of high-volume, short-duration retail supply relationships and a smaller portfolio of licensing/health contracts that deliver recurring revenue. Two mass retailers account for roughly half of HBB’s revenue, trade receivables are highly concentrated among a few customers, and the company runs both product distribution and IP/licensing businesses—each with different margin and risk profiles.
How HBB contracts and where risk concentrates
HBB sells primarily on individual purchase orders to retailers and ecommerce platforms, not under long-term supply contracts. The company also operates as a licensor and lessor in its Health and branded partnerships. From a business-model perspective:
- Contracting posture: Predominantly short-term customer contracts and purchase orders; Health device leases are month-to-month, and licensing deals exist for brands and software. This creates predictable transactional flows but limited contractual protection against demand shifts.
- Customer concentration and criticality: Highly concentrated—the five largest customers contributed ~65% of revenue in 2024, and two customers generated $189.3M and $154.1M respectively—making HBB exposed to order volatility or retail inventory adjustments.
- Revenue mix maturity: Core hardware/distribution is mature and seasonal (holiday-driven), while Health (software/licenses and device leases) is an emerging, smaller recurring component.
- Geography: North America–centric (roughly two-thirds of commercial sales) with global distribution and EMEA/APAC presence that introduces FX and regulatory exposures.
These are company-level signals taken from HBB’s FY2024 disclosures and subsequent news. The explicit retail concentration with Walmart and Amazon is noted in the filings.
Customer relationship roll-call (plain-English summaries with sources)
Walmart Inc.
Walmart accounted for approximately 29% of HBB’s revenue in 2024, and has been a consistent high-volume retail customer across recent years. According to HBB’s 2024 Form 10‑K, Walmart and its subsidiaries represented ~29% of consolidated revenue in FY2024. (HBB 10‑K, FY2024)
Amazon.com, Inc.
Amazon accounted for approximately 24% of HBB’s revenue in 2024, making it the other dominant retail channel for HBB’s consumer appliance sales. This concentration is disclosed in HBB’s 2024 Form 10‑K. (HBB 10‑K, FY2024)
Sunkist
HBB has multiyear agreements to design, market and distribute Sunkist-branded commercial juicers and sectionizers, a brand-license relationship that expands HBB’s commercial appliance set. This was referenced in HBB investor releases and PR reporting in FY2026 and FY2025. (PR Newswire; SahmCapital, FY2025–FY2026)
Numilk
HBB holds multiyear agreements to design and distribute Numilk plant‑based milk makers, an exclusive-brand arrangement that supports product diversification in specialty appliances. Media releases and investor communications note these agreements in FY2025–FY2026. (PR Newswire; Finviz; SahmCapital, FY2025–FY2026)
Clorox (CLX)
HBB licenses Clorox and associated brands for home appliances (including Clorox™ home appliances and Clorox True HEPA air purifiers) and also partners on Brita Hub appliances, positioning HBB as a licensor/operator of co‑branded products. Coverage in FY2025–FY2026 PR and financial news highlights these licensing arrangements. (PR Newswire; Finviz; Yahoo Finance, FY2025–FY2026)
Bartesian
HBB has exclusive multiyear agreements to design, sell and distribute Bartesian cocktail makers, integrating a specialty consumer appliance brand into its portfolio. This relationship is cited in HBB press releases and PR filings (FY2025). (PR Newswire; Yahoo Finance, FY2025)
Brita Hub
HBB licenses and manufactures Brita Hub countertop electric water filtration appliances under agreement with the Brita brand, linking HBB to established consumer water-filtration branding. Press releases from FY2025 document the licensed arrangement. (PR Newswire; Yahoo Finance, FY2025)
CHI (CHICF)
HBB licenses CHI® premium garment care products for distribution, reflecting HBB’s strategy to take on co‑branded, premium small‑appliance lines. Multiple investor notices and PR items from FY2025–FY2026 reference this licensing relationship. (PR Newswire; Barchart; SahmCapital, FY2025–FY2026)
Wolf Gourmet
HBB holds licensing rights for Wolf Gourmet countertop appliances, showing HBB’s participation in premium kitchenware branding beyond its own label. Market reports and company statements in FY2026 include Wolf Gourmet in the suite of licensed brands. (Quantisnow; FY2026 press)
Bartesian / Numilk (exclusive multiyear)
As noted, HBB’s exclusive multiyear agreements for Bartesian and Numilk are material to its specialty appliance growth strategy; the company called these out in its FY2024 and FY2025 earnings releases. (PR Newswire; FY2025)
Lumicera
Lumicera is named among new specialty pharmacy partners in HBB’s Health segment commentary, indicating HBB’s expansion of device leasing and software services with specialty-provider partners in FY2026. (Investing.com transcript, FY2026)
Novartis (NVS)
HBB reported launching HealthBeacon Harmony software products with Novartis, representing a strategic enterprise software/license deployment in the Health segment and validating HBB’s healthcare partnerships in FY2026. (Investing.com transcript, FY2026)
Synerwell
Synerwell is cited as another specialty pharmacy partner in HBB’s Health segment communications, reflecting the roll-out of leased connected devices and subscription services to pharmacy networks in FY2026. (Investing.com transcript, FY2026)
Cartesian (CRTN)
HBB disclosed a license agreement expiration with Cartesian at the end of 2025 that represented an estimated ~$22 million sales headwind—this is an identified, measurable contract transition announced in earnings commentary. (Investing.com transcript citing Q4 2025, FY2026 commentary)
Brita (BLSIF)
Beyond Brita Hub products, HBB’s licensing mention of Brita branding for certain countertop appliances ties it to legacy household water‑filtration IP in FY2025 reporting. (Quantisnow; FY2025 PR)
(Note: multiple news and investor releases from FY2025–FY2026 document these brand and Health partnerships; the company’s 2024 Form 10‑K provides baseline customer concentration figures.)
Investment implications and read‑throughs
- Concentration risk is the central investor thesis: roughly two customers (Walmart and Amazon) and the five largest customers drive a majority of revenue; that creates earnings sensitivity to retail demand and inventory cycles. (HBB 10‑K, FY2024)
- Contracting mixes lower downside protection for product sales because most retail demand is transacted via purchase orders rather than fixed long‑term supply contracts; the Health segment provides a counterbalancing recurring revenue stream through leases and software licensing, but it is still smaller in scale. (HBB 10‑K and segment notes, FY2024)
- Brand licensing and exclusive product partnerships (Bartesian, Numilk, Sunkist, Clorox/CHI/Wolf/Gourmet/Brita) diversify market exposure and support margin expansion on co‑branded, higher‑value products; pay attention to the timing and renewal of those multiyear agreements. (PR Newswire; FY2025–FY2026)
For a structured view of HBB’s customer exposure and named counterparties, visit the HBB customer map at https://nullexposure.com/.